[go: up one dir, main page]

MX9203615A - Composicion farmaceutica en forma de polvo para administracion nasal. - Google Patents

Composicion farmaceutica en forma de polvo para administracion nasal.

Info

Publication number
MX9203615A
MX9203615A MX9203615A MX9203615A MX9203615A MX 9203615 A MX9203615 A MX 9203615A MX 9203615 A MX9203615 A MX 9203615A MX 9203615 A MX9203615 A MX 9203615A MX 9203615 A MX9203615 A MX 9203615A
Authority
MX
Mexico
Prior art keywords
powder
pharmaceutical composition
nasal administration
nasal
administration
Prior art date
Application number
MX9203615A
Other languages
English (en)
Inventor
Annie Rassing Hoelgaard
Birgitte Smedemark Dath
Linda Mindeholm
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of MX9203615A publication Critical patent/MX9203615A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Inorganic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MX9203615A 1991-03-20 1992-06-26 Composicion farmaceutica en forma de polvo para administracion nasal. MX9203615A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK91497A DK49791D0 (da) 1991-03-20 1991-03-20 Nasalt pulverpraeparat

Publications (1)

Publication Number Publication Date
MX9203615A true MX9203615A (es) 1992-09-01

Family

ID=8094234

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9203615A MX9203615A (es) 1991-03-20 1992-06-26 Composicion farmaceutica en forma de polvo para administracion nasal.

Country Status (5)

Country Link
AU (1) AU1468792A (es)
DK (1) DK49791D0 (es)
MX (1) MX9203615A (es)
WO (1) WO1992016196A1 (es)
ZA (1) ZA922006B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1006873A6 (nl) * 1993-03-26 1995-01-10 Merkus Franciscus W H M Toedieningsformulering voor nasale insuline toediening.
JP3098401B2 (ja) * 1995-07-12 2000-10-16 株式会社エルティーティー研究所 経鼻投与用製剤
JP2006500387A (ja) * 2002-08-15 2006-01-05 雲清 劉 固形ナノ医薬およびその調製方法
US20050031549A1 (en) * 2003-06-09 2005-02-10 Nastech Pharmaceutical Company Inc. Compositions and methods for enhanced mucosal delivery of growth hormone
JP5254618B2 (ja) * 2004-10-11 2013-08-07 ナサリーズ・ピーピーエム・リミテッド 経鼻投与用組成物
GB0422582D0 (en) * 2004-10-11 2004-11-10 Nasaleze Patents Ltd Pharmaceutical compositions
US8202550B2 (en) 2004-10-11 2012-06-19 Nasaleze Ppm Limited Compositions for intranasal administration
EP2046284A1 (en) * 2006-08-04 2009-04-15 Nastech Pharmaceutical Company Inc. Compositions for intranasal delivery of human insulin and uses thereof
PT3258919T (pt) * 2015-02-17 2020-03-26 Lilly Co Eli Formulação em pó nasal para tratamento da hipoglicemia
TWI771669B (zh) * 2019-04-26 2022-07-21 美商美國禮來大藥廠 製備穩定胜肽調配物之方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59163313A (ja) * 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
IL78425A (en) * 1985-04-15 1991-05-12 Lilly Co Eli Intranasal formulation containing insulin
GB8712176D0 (en) * 1987-05-22 1987-06-24 Cosmas Damian Ltd Drug delivery system
NL9001681A (nl) * 1990-07-24 1992-02-17 Rijksuniversiteit Transmucosale geneesmiddelpreparaten en transmucosale toediening.

Also Published As

Publication number Publication date
WO1992016196A1 (en) 1992-10-01
ZA922006B (en) 1992-11-25
AU1468792A (en) 1992-10-21
DK49791D0 (da) 1991-03-20

Similar Documents

Publication Publication Date Title
MX9101175A (es) Composicion farmaceutica para administracion nasal
IT9020025A0 (it) Dispositivo per la somministrazione di sostanze medicamentose in polvere
MX9203263A (es) Composicion farmaceutica analgesica para administracion nasal.
FI924247A7 (fi) Annostusmuoto lääkkeen vapauttamiseksi suoleen
FI922958L (fi) Farmaceutisk sammansaettning
FI981777A7 (fi) Farmaseuttinen ainekoostumus
FI922316L (fi) Farmaceutisk sammansaettning
DE69101931D1 (de) Pharmazeutische Zusammensetzung.
IS3878A (is) Imidazodiazepines efnasambönd, framleiðsla þeirraog notkun sem lyfja
ITMI921930A1 (it) Composizioni farmaceutiche per la somministrazione orale di diidropiridine in forma di bevanda
PH31073A (en) Pharmaceutical composition and process for the preparation thereof.
FI970331A0 (fi) Lääkkeen antokoostumus virustenvastaisten aineiden nenään toteutettavaa antoa varten
EP0448091A3 (en) Pharmaceutical composition containing slightly water-soluble drug
DZ1559A1 (fr) Compositions pharmaceutiques.
MX9203615A (es) Composicion farmaceutica en forma de polvo para administracion nasal.
FI910088L (fi) Oral farmaceutisk komposition.
GB9123353D0 (en) New mercapto-amide derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same
IT9019112A1 (it) Composizioni farmaceutiche e forme di dosaggio per la somministrazione orale di calcitonina
MX9100357A (es) Composiciones farmaceuticas estabilizadas y procedimiento para su preparacion
BR9607433A (pt) Composição farmacêutica para administração parental
ITRM920535A1 (it) Composizione farmaceutica per la somministrazione attraverso le mucose.
IT8219012A0 (it) Metodo per la somministrazione orale di sostanze sotto forma di liposomi, e relative formulazioni farmaceutiche.
IT8722647A0 (it) Composizione farmaceutica per somministrazione nasale.
IT9048244A0 (it) Composizione farmaceutica ad effetto cicatrizzante.
IT8819541A0 (it) Composizione farmaceutica per somministrazione nasale.